BLCM
Vanguard Group’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-66,309
| Closed | -$21.9K | – | 4600 |
|
|
2023
Q1 | $21.9K | Sell |
66,309
-115,534
| -64% | -$38.1K | ﹤0.01% | 4525 |
|
|
2022
Q4 | $131K | Sell |
181,843
-182,877
| -50% | -$132K | ﹤0.01% | 4362 |
|
|
2022
Q3 | $437K | Hold |
364,720
| – | – | ﹤0.01% | 4250 |
|
|
2022
Q2 | $434K | Hold |
364,720
| – | – | ﹤0.01% | 4323 |
|
|
2022
Q1 | $788K | Sell |
364,720
-65,358
| -15% | -$141K | ﹤0.01% | 4282 |
|
|
2021
Q4 | $640K | Hold |
430,078
| – | – | ﹤0.01% | 4378 |
|
|
2021
Q3 | $1.26M | Buy |
430,078
+5,767
| +1% | +$16.8K | ﹤0.01% | 4193 |
|
|
2021
Q2 | $1.4M | Buy |
424,311
+223,524
| +111% | +$738K | ﹤0.01% | 4072 |
|
|
2021
Q1 | $755K | Buy |
200,787
+32,022
| +19% | +$120K | ﹤0.01% | 4063 |
|
|
2020
Q4 | $596K | Sell |
168,765
-5,238
| -3% | -$18.5K | ﹤0.01% | 3927 |
|
|
2020
Q3 | $1.14M | Sell |
174,003
-2,353
| -1% | -$15.5K | ﹤0.01% | 3627 |
|
|
2020
Q2 | $1.31M | Sell |
176,356
-11,924
| -6% | -$88.6K | ﹤0.01% | 3543 |
|
|
2020
Q1 | $887K | Sell |
188,280
-1,590,646
| -89% | -$7.49M | ﹤0.01% | 3521 |
|
|
2019
Q4 | $2.3M | Hold |
1,778,926
| – | – | ﹤0.01% | 3411 |
|
|
2019
Q3 | $1.87M | Sell |
1,778,926
-98,405
| -5% | -$103K | ﹤0.01% | 3470 |
|
|
2019
Q2 | $3.19M | Sell |
1,877,331
-353,748
| -16% | -$601K | ﹤0.01% | 3324 |
|
|
2019
Q1 | $7.52M | Buy |
2,231,079
+274,862
| +14% | +$926K | ﹤0.01% | 2976 |
|
|
2018
Q4 | $5.71M | Buy |
1,956,217
+8,375
| +0.4% | +$24.5K | ﹤0.01% | 3029 |
|
|
2018
Q3 | $12M | Buy |
1,947,842
+23,410
| +1% | +$144K | ﹤0.01% | 2828 |
|
|
2018
Q2 | $14.2M | Buy |
1,924,432
+575,132
| +43% | +$4.24M | ﹤0.01% | 2728 |
|
|
2018
Q1 | $8.85M | Sell |
1,349,300
-12,057
| -0.9% | -$79.1K | ﹤0.01% | 2879 |
|
|
2017
Q4 | $11.4M | Buy |
1,361,357
+149,082
| +12% | +$1.25M | ﹤0.01% | 2754 |
|
|
2017
Q3 | $14M | Buy |
1,212,275
+5,839
| +0.5% | +$67.4K | ﹤0.01% | 2654 |
|
|
2017
Q2 | $14.1M | Buy |
1,206,436
+144,854
| +14% | +$1.69M | ﹤0.01% | 2609 |
|
|
2017
Q1 | $13.1M | Buy |
1,061,582
+160,151
| +18% | +$1.98M | ﹤0.01% | 2634 |
|
|
2016
Q4 | $12.3M | Buy |
901,431
+26,378
| +3% | +$359K | ﹤0.01% | 2653 |
|
|
2016
Q3 | $17.4M | Buy |
875,053
+123,469
| +16% | +$2.46M | ﹤0.01% | 2424 |
|
|
2016
Q2 | $9.74M | Buy |
751,584
+64,345
| +9% | +$834K | ﹤0.01% | 2662 |
|
|
2016
Q1 | $6.43M | Buy |
687,239
+31,557
| +5% | +$295K | ﹤0.01% | 2835 |
|
|
2015
Q4 | $13.3M | Buy |
655,682
+66,567
| +11% | +$1.35M | ﹤0.01% | 2482 |
|
|
2015
Q3 | $8.56M | Buy |
589,115
+308,967
| +110% | +$4.49M | ﹤0.01% | 2686 |
|
|
2015
Q2 | $5.96M | Buy |
280,148
+60,981
| +28% | +$1.3M | ﹤0.01% | 2924 |
|
|
2015
Q1 | $5.08M | Buy |
219,167
+154,167
| +237% | +$3.57M | ﹤0.01% | 2995 |
|
|
2014
Q4 | $1.5M | Buy |
+65,000
| New | +$1.5M | ﹤0.01% | 3379 |
|